Formosa Laboratories, Inc. (4746.TW)
TWD 71.9
(-0.96%)
TWD 71.9
(-0.96%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 13.63 Billion TWD | 6.94% |
| 2022 | 12.75 Billion TWD | 6.11% |
| 2021 | 12.01 Billion TWD | 16.83% |
| 2020 | 10.28 Billion TWD | 7.05% |
| 2019 | 9.6 Billion TWD | 10.12% |
| 2018 | 8.72 Billion TWD | 20.49% |
| 2017 | 7.24 Billion TWD | 7.53% |
| 2016 | 6.73 Billion TWD | 4.31% |
| 2015 | 6.45 Billion TWD | 13.46% |
| 2014 | 5.69 Billion TWD | 14.01% |
| 2013 | 4.99 Billion TWD | 23.67% |
| 2012 | 4.03 Billion TWD | 29.62% |
| 2011 | 3.11 Billion TWD | 31.08% |
| 2010 | 2.37 Billion TWD | 0.0% |
| 2009 | - TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 13.4 Billion TWD | 0.08% |
| 2024 Q1 | 13.39 Billion TWD | -1.75% |
| 2023 FY | 13.63 Billion TWD | 6.94% |
| 2023 Q4 | 13.63 Billion TWD | 2.52% |
| 2023 Q3 | 13.3 Billion TWD | -1.9% |
| 2023 Q2 | 13.55 Billion TWD | 8.08% |
| 2023 Q1 | 12.54 Billion TWD | -1.62% |
| 2022 Q1 | 11.39 Billion TWD | -5.2% |
| 2022 Q4 | 12.75 Billion TWD | 3.93% |
| 2022 Q2 | 11.38 Billion TWD | -0.06% |
| 2022 FY | 12.75 Billion TWD | 6.11% |
| 2022 Q3 | 12.26 Billion TWD | 7.76% |
| 2021 Q1 | 12.05 Billion TWD | 17.24% |
| 2021 Q2 | 12.67 Billion TWD | 5.08% |
| 2021 FY | 12.01 Billion TWD | 16.83% |
| 2021 Q3 | 12.17 Billion TWD | -3.96% |
| 2021 Q4 | 12.01 Billion TWD | -1.27% |
| 2020 FY | 10.28 Billion TWD | 7.05% |
| 2020 Q1 | 9.83 Billion TWD | 2.38% |
| 2020 Q3 | 10.47 Billion TWD | -0.5% |
| 2020 Q4 | 10.28 Billion TWD | -1.82% |
| 2020 Q2 | 10.52 Billion TWD | 7.04% |
| 2019 FY | 9.6 Billion TWD | 10.12% |
| 2019 Q4 | 9.6 Billion TWD | 3.66% |
| 2019 Q3 | 9.26 Billion TWD | 2.15% |
| 2019 Q2 | 9.07 Billion TWD | 0.07% |
| 2019 Q1 | 9.06 Billion TWD | 3.93% |
| 2018 Q3 | 7.76 Billion TWD | -0.16% |
| 2018 Q2 | 7.77 Billion TWD | 2.92% |
| 2018 Q1 | 7.55 Billion TWD | 4.31% |
| 2018 FY | 8.72 Billion TWD | 20.49% |
| 2018 Q4 | 8.72 Billion TWD | 12.41% |
| 2017 Q1 | 6.76 Billion TWD | 0.41% |
| 2017 Q4 | 7.24 Billion TWD | 5.2% |
| 2017 Q3 | 6.88 Billion TWD | -1.55% |
| 2017 Q2 | 6.99 Billion TWD | 3.4% |
| 2017 FY | 7.24 Billion TWD | 7.53% |
| 2016 Q1 | 6.76 Billion TWD | 4.81% |
| 2016 Q4 | 6.73 Billion TWD | 0.43% |
| 2016 Q2 | 6.94 Billion TWD | 2.59% |
| 2016 FY | 6.73 Billion TWD | 4.31% |
| 2016 Q3 | 6.7 Billion TWD | -3.4% |
| 2015 Q3 | 5.89 Billion TWD | 1.56% |
| 2015 FY | 6.45 Billion TWD | 13.46% |
| 2015 Q4 | 6.45 Billion TWD | 9.52% |
| 2015 Q2 | 5.8 Billion TWD | -0.67% |
| 2015 Q1 | 5.84 Billion TWD | 2.69% |
| 2014 Q2 | 5.04 Billion TWD | 3.17% |
| 2014 Q1 | 4.89 Billion TWD | -2.0% |
| 2014 Q4 | 5.69 Billion TWD | 8.41% |
| 2014 FY | 5.69 Billion TWD | 14.01% |
| 2014 Q3 | 5.24 Billion TWD | 4.03% |
| 2013 Q1 | 3.99 Billion TWD | -1.1% |
| 2013 Q2 | 4.41 Billion TWD | 10.63% |
| 2013 Q3 | 4.88 Billion TWD | 10.58% |
| 2013 Q4 | 4.99 Billion TWD | 2.23% |
| 2013 FY | 4.99 Billion TWD | 23.67% |
| 2012 Q4 | 4.03 Billion TWD | 7.77% |
| 2012 Q1 | 3.3 Billion TWD | 6.06% |
| 2012 Q2 | 3.52 Billion TWD | 6.79% |
| 2012 FY | 4.03 Billion TWD | 29.62% |
| 2012 Q3 | 3.74 Billion TWD | 6.19% |
| 2011 Q3 | 2.85 Billion TWD | 12.45% |
| 2011 Q4 | 3.11 Billion TWD | 9.16% |
| 2011 Q1 | 2.43 Billion TWD | 2.55% |
| 2011 Q2 | 2.53 Billion TWD | 4.13% |
| 2011 FY | 3.11 Billion TWD | 31.08% |
| 2010 FY | 2.37 Billion TWD | 0.0% |
| 2010 Q4 | 2.37 Billion TWD | 0.0% |
| 2009 FY | - TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Grape King Bio Ltd | 15.51 Billion TWD | 12.092% |
| Standard Chem & Pharm CO., LTD. | 11.18 Billion TWD | -21.874% |
| Maywufa Company Ltd. | 2.83 Billion TWD | -381.492% |
| ScinoPharm Taiwan, Ltd. | 11.72 Billion TWD | -16.334% |
| Lotus Pharmaceutical Co., Ltd. | 32.99 Billion TWD | 58.668% |
| LIWANLI Innovation Co., Ltd. | 834.17 Million TWD | -1534.696% |
| YungShin Global Holding Corporation | 11.51 Billion TWD | -18.448% |
| PhytoHealth Corporation | 2.35 Billion TWD | -480.137% |
| SCI Pharmtech, Inc. | 6.69 Billion TWD | -103.807% |
| PharmaEssentia Corporation | 27.26 Billion TWD | 49.994% |
| Bora Pharmaceuticals Co., LTD. | 25.05 Billion TWD | 45.568% |